Working… Menu

A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02026271
Recruitment Status : Unknown
Verified June 2019 by Ziopharm.
Recruitment status was:  Active, not recruiting
First Posted : January 1, 2014
Last Update Posted : June 17, 2019
Information provided by (Responsible Party):